Latest / No Brain Behind / Changing the Story of Multiple Sclerosis in Africa
Transcript
- 1 00:00:00,000 --> 00:00:09,720 On behalf of the Society for Equity Neuroscience, welcome to No Brain Behind. 2 00:00:09,720 --> 00:00:15,120 The mission of the Society for Equity Neuroscience or Sequence is to enhance brain health equity 3 00:00:15,120 --> 00:00:17,160 through scientific research. 4 00:00:17,160 --> 00:00:22,600 This podcast is dedicated to conversations with equity-focused neuroscientists and thought 5 00:00:22,600 --> 00:00:23,760 leaders. 6 00:00:23,760 --> 00:00:29,560 Our guests are working to understand and address barriers to and facilitators of optimal brain 7 00:00:29,560 --> 00:00:33,520 health and nervous system function for everyone, everywhere. 8 00:00:33,520 --> 00:00:38,800 No brain behind explores cutting-edge research methods, amplifies new discoveries and 9 00:00:38,800 --> 00:00:42,400 boasters collaboration within the scientific community. 10 00:00:42,400 --> 00:00:44,440 I'm Dr. Geathange Liedas. 11 00:00:44,440 --> 00:00:48,320 I am Dr. Annalkadenatehada and I'm Dr. Chris Orlando. 12 00:00:48,320 --> 00:00:53,480 We are a clinician scientists in the field of health equity neuroscience who have the 13 00:00:53,480 --> 00:00:58,280 distant pleasure of being your host on No Brain Behind. 14 00:00:58,280 --> 00:01:04,840 Join us as explore the scientific challenges and innovations shaping the future of equity 15 00:01:04,840 --> 00:01:06,840 neuroscience. 16 00:01:06,840 --> 00:01:12,440 Hello and welcome to another episode of No Brain Behind. 17 00:01:12,440 --> 00:01:18,920 I am your host, Dr. Geathange Liedas and today I'm very excited to welcome our guest, Dr. 18 00:01:18,920 --> 00:01:25,000 Fiifi Duodu, who is a neurologist who works in Ghana and he has spent a good amount of 19 00:01:25,000 --> 00:01:30,800 time working on improving the care for patients who have multiple sclerosis through creating 20 00:01:30,800 --> 00:01:35,520 a multiple sclerosis registry and working with different providers who help provide the 21 00:01:35,520 --> 00:01:38,520 care for our MS patients in Ghana. 22 00:01:38,520 --> 00:01:43,920 Dr. Duodu, do you mind telling us a little bit about yourself and what inspired you to 23 00:01:43,920 --> 00:01:46,640 focus on MS care in Africa? 24 00:01:46,640 --> 00:01:47,640 Sure. 25 00:01:47,640 --> 00:01:51,960 Yeah, so like you said, my name is Fiifi Duodu. 26 00:01:51,960 --> 00:01:59,640 I'm a neurologist in Ghana but I, of course currently I'm a specialist in multiple sclerosis 27 00:01:59,640 --> 00:02:05,800 and other deminingating diseases and back home in Ghana I work with a teaching hospital that 28 00:02:05,800 --> 00:02:11,520 is the biggest referral site in the country, the largest in the West African sub region and 29 00:02:11,520 --> 00:02:16,600 where we have about six neurologists taking care of about, close to about 10 million individuals 30 00:02:16,600 --> 00:02:20,600 but the whole country has about 18 million, 18 neurologists. 31 00:02:20,600 --> 00:02:24,880 I might say apart from taking care of multiple sclerosis, I take care of other general neurology 32 00:02:24,880 --> 00:02:30,960 cases and in some cases even see other internal medicine cases which is quite mandatory 33 00:02:30,960 --> 00:02:35,440 of a specialist in the clinical lack of specialist. 34 00:02:35,440 --> 00:02:41,680 I came to Paul and Laura with multiple sclerosis, I take care of patient, multiple sclerosis, 35 00:02:41,680 --> 00:02:48,440 when I first went to Zambia and I went to Zambia to meet my mentor, was an elective program 36 00:02:48,440 --> 00:02:51,080 and this was in 2022. 37 00:02:51,080 --> 00:02:57,640 So in 2022 and she's Professor Diana Seila, she's currently a resident of Coroneliner. 38 00:02:57,640 --> 00:03:04,840 And so when I went there initially, she did actually mention whether I have, I was, do I 39 00:03:04,840 --> 00:03:09,640 have multiple sclerosis patients back home in Ghana and I said, well, we've seen just a couple 40 00:03:09,640 --> 00:03:14,080 of them and I don't think we have a lot of multiple sclerosis in Ghana. 41 00:03:14,080 --> 00:03:17,400 So okay, why don't you just go back home and set up a registry? 42 00:03:17,400 --> 00:03:21,080 You might be surprised that I'm more than you think and actually look after them. 43 00:03:21,080 --> 00:03:27,360 So I go back home and then to my surprise, I mean, we studied, I mean most of the patients 44 00:03:27,360 --> 00:03:31,320 are seeing us looking after multiple sclerosis and I got to know that we have quite a number 45 00:03:31,320 --> 00:03:33,920 of them in Ghana. 46 00:03:33,920 --> 00:03:38,160 And I called and I said, well, I think she's right, the issue was that we're not looking 47 00:03:38,160 --> 00:03:43,440 after them really and most of them were sort of being sort of other cases. 48 00:03:43,440 --> 00:03:49,640 And fast forward, we wrote a grant for the MSI of the pre-war and she was my host and so 49 00:03:49,640 --> 00:03:56,880 I went to Zambia again because we had an established registry ongoing and so I had to go there 50 00:03:56,880 --> 00:04:00,640 to understand it and so I can come back home and set up a registry. 51 00:04:00,640 --> 00:04:07,400 And then the questions to La Rue and she said that as part of me set up the registry, we 52 00:04:07,400 --> 00:04:12,600 sort of educate the healthcare providers where most of this piece in my seat without seeing 53 00:04:12,600 --> 00:04:13,920 us fast. 54 00:04:13,920 --> 00:04:17,840 And by that she really worked, she made most of them were general practitioners without any 55 00:04:17,840 --> 00:04:21,480 specialty or even of terminologies and some sort of surgeons. 56 00:04:21,480 --> 00:04:25,920 So the initial goal was to do the education for Ghanaian doctors, but we said, why don't we 57 00:04:25,920 --> 00:04:32,760 spread across the whole continent and so we did our continent, our MSVSR course and about 58 00:04:32,760 --> 00:04:35,360 800 participants were involved. 59 00:04:35,360 --> 00:04:39,760 And after that, I went back home because most of the Ghanaian doctors were involved. 60 00:04:39,760 --> 00:04:44,360 There was a certain stage of referrals of symptoms that looked like MS. 61 00:04:44,360 --> 00:04:45,960 Most of them were MS somewhere not. 62 00:04:45,960 --> 00:04:47,640 It was a good thing to start off. 63 00:04:47,640 --> 00:04:53,080 So if I registered as that of less than 20, suddenly jumped up to 50 and currently we 64 00:04:53,080 --> 00:05:00,440 have 120 something patients with MS and MMO and also few mocks. 65 00:05:00,440 --> 00:05:03,640 So that's how I got involved with multiple scores. 66 00:05:03,640 --> 00:05:09,080 And ever since I've enjoyed doing it and I set up a clinic on every Tuesdays to see the 67 00:05:09,080 --> 00:05:12,600 patients as the population sort of tend to grow. 68 00:05:12,600 --> 00:05:13,600 Thank you. 69 00:05:13,600 --> 00:05:15,880 Well, that's really impressive. 70 00:05:15,880 --> 00:05:20,800 I enjoy hearing about how this is kind of an ongoing project and that you're still seeing 71 00:05:20,800 --> 00:05:23,040 a lot of growth in it. 72 00:05:23,040 --> 00:05:30,320 But you kind of touched on this a little bit that it about kind of what the next question 73 00:05:30,320 --> 00:05:36,320 for you is what did MS care look like when you entered the field and you kind of did touch 74 00:05:36,320 --> 00:05:41,320 on it a little bit by saying that when you started you didn't really think there were too many 75 00:05:41,320 --> 00:05:42,640 MS patients. 76 00:05:42,640 --> 00:05:48,160 But what are you seeing now compared to when you first started? 77 00:05:48,160 --> 00:05:56,080 MS care was first of all was chronic, I mean, it was not tough and one in two ways, there 78 00:05:56,080 --> 00:05:57,400 was no patients awareness. 79 00:05:57,400 --> 00:05:59,240 They didn't even know anything called MS. 80 00:05:59,240 --> 00:06:04,920 They knew the stroves and the Parkinson's and the epilepsy's patients themselves didn't 81 00:06:04,920 --> 00:06:06,320 know about MS. 82 00:06:06,320 --> 00:06:11,360 And interesting was not just the patients was also the health professionals because back then 83 00:06:11,360 --> 00:06:17,960 in the medical school, I don't remember being taught about MS in medical school. 84 00:06:17,960 --> 00:06:23,240 And we didn't see any even as being a doctor until I started neurology that I saw one or 85 00:06:23,240 --> 00:06:24,240 two. 86 00:06:24,240 --> 00:06:30,360 This is because I think the awareness is very low and most of these patients actually tend 87 00:06:30,360 --> 00:06:37,240 to see general practices who to just start off with don't think MS exists and really just 88 00:06:37,240 --> 00:06:40,440 sort of think the symptoms might be due to something else. 89 00:06:40,440 --> 00:06:44,360 And even if somebody would ever think of MS, but would be maybe the 10th difference if you 90 00:06:44,360 --> 00:06:47,360 could say so they don't really sort of work it out. 91 00:06:47,360 --> 00:06:53,160 And if a neurologist sort of thinks about it then the patients also go through a lot of 92 00:06:53,160 --> 00:06:56,440 challenges, a lot of diagnostic challenges. 93 00:06:56,440 --> 00:07:02,120 And these challenges are the imaging, the power, power, clear cards, which you need to establish 94 00:07:02,120 --> 00:07:06,200 the diagnosis because most of these were not available. 95 00:07:06,200 --> 00:07:12,920 We have some MRIs, but cryoconcetrated in the air band south and most of them have other 96 00:07:12,920 --> 00:07:14,840 places to as well. 97 00:07:14,840 --> 00:07:18,120 And there was a lot of breakdown of these machines. 98 00:07:18,120 --> 00:07:22,400 Also the number of point says her resource was expensive and he had to go all the way back 99 00:07:22,400 --> 00:07:24,440 to other countries other than even Africa. 100 00:07:24,440 --> 00:07:29,720 And so it took a long time and just to talk about about it, even if the diagnosis was 101 00:07:29,720 --> 00:07:36,400 being made, really the challenges of getting the medication was another tough issue because 102 00:07:36,400 --> 00:07:44,120 there's all out of pocket payment from diagnostics to treatment of out of pocket treatment. 103 00:07:44,120 --> 00:07:49,240 Yes, so we were forward in 2023 when I started the registered training for an after like 104 00:07:49,240 --> 00:07:53,960 a set after the established the MSV track course. 105 00:07:53,960 --> 00:07:58,560 People or the healthcare professionals, we have sessions for our of the neurologist, we 106 00:07:58,560 --> 00:08:03,160 have sessions for the general surgeons, the new the new surgeons, so they all joined and 107 00:08:03,160 --> 00:08:06,920 so they don't know that look, I could refer a suspected case. 108 00:08:06,920 --> 00:08:11,320 And for example, the of the knowledge now when it's in death, it's just an optic myriotis 109 00:08:11,320 --> 00:08:16,880 to actual previous events of other neurological conditions and now even referred to this as 110 00:08:16,880 --> 00:08:20,360 of this one just before this interview, I had a call from another pharmacologist, actually 111 00:08:20,360 --> 00:08:25,360 suspecting patients with even more than it or MS that she wants to refer to the clinic. 112 00:08:25,360 --> 00:08:30,560 So there was those an awareness created among the clinicians and so they could sort of 113 00:08:30,560 --> 00:08:34,520 refer to the teaching hospital where we could make a diagnosis. 114 00:08:34,520 --> 00:08:39,080 Moving forward again, like I said, the diagnosis became a challenge, but thankfully again thanks 115 00:08:39,080 --> 00:08:46,640 to my mentor, Dr. Proseta, I mean, we took the most really introduced on on the WHO essential 116 00:08:46,640 --> 00:08:47,840 drug list. 117 00:08:47,840 --> 00:08:55,320 And our country in South Africa, we many use for half insurance and that's now the drug 118 00:08:55,320 --> 00:08:56,320 has to be on the essential drug. 119 00:08:56,320 --> 00:08:58,640 If it's not on it, it's going to be sure. 120 00:08:58,640 --> 00:09:04,240 So we had a push and then again, by my patient because of that, for the patient who 121 00:09:04,240 --> 00:09:10,600 this patient also came up with their own sort of organization or patients group and recording 122 00:09:10,600 --> 00:09:12,000 navigating life through MS. 123 00:09:12,000 --> 00:09:15,840 But one of my patients actually pushed and knew some people in government and said look, 124 00:09:15,840 --> 00:09:17,920 this thing had to be covered on insurance. 125 00:09:17,920 --> 00:09:20,720 So on the board, they did ask me to have data and I put it in. 126 00:09:20,720 --> 00:09:24,440 Of course, I have a lot of patients that were surprised to have to see this case. 127 00:09:24,440 --> 00:09:26,920 And then two, they asked, look, real medical patients are expensive. 128 00:09:26,920 --> 00:09:32,080 So, thankfully, we have a big tourism app on WHO essential drug list, which the insurance 129 00:09:32,080 --> 00:09:39,920 was even then insuring for other conditions like Bakedit, Sling, Fumar and other other conditions. 130 00:09:39,920 --> 00:09:40,920 So it was quite easy. 131 00:09:40,920 --> 00:09:46,000 And at the time, they've actually accepted our half insurance and very soon they're going 132 00:09:46,000 --> 00:09:50,520 to really have a patient and not just the medication, they're also taking care of the cost 133 00:09:50,520 --> 00:09:55,960 of the diagnostic as well as the treatment. 134 00:09:55,960 --> 00:09:59,000 And so there's a lot of good news out there for the patients now. 135 00:09:59,000 --> 00:10:03,080 I mean, the doctors are more aware about it and it doesn't end there. 136 00:10:03,080 --> 00:10:06,920 They don't need to pay a lot of money to even get their diagnosis being made and also 137 00:10:06,920 --> 00:10:07,920 their treatment. 138 00:10:07,920 --> 00:10:13,760 So that's how the transition from very little to where we are now. 139 00:10:13,760 --> 00:10:19,400 That's really cool that just kind of starting with like building that first registry has 140 00:10:19,400 --> 00:10:28,440 really expanded not just the diagnosis, but also being able to receive care and like 141 00:10:28,440 --> 00:10:33,400 proceed with treatment for your patients. 142 00:10:33,400 --> 00:10:40,640 I think one of my other questions is about this registry itself and I wanted to know more 143 00:10:40,640 --> 00:10:46,320 about kind of what data you're collecting through it and what you've learned from that 144 00:10:46,320 --> 00:10:47,320 data. 145 00:10:47,320 --> 00:10:48,320 Yes. 146 00:10:48,320 --> 00:10:51,840 So I also really learned a lot when I went to Zambia and hard data and I was just a bit registered. 147 00:10:51,840 --> 00:10:57,240 I had never set up a registry, but so this registry was mainly about demagnet and diseases 148 00:10:57,240 --> 00:10:58,240 was not just only MS. 149 00:10:58,240 --> 00:11:03,400 We also had NMO and more to as well in the registry. 150 00:11:03,400 --> 00:11:09,960 And so the registry sort of takes their demographics from their age and also social, 151 00:11:09,960 --> 00:11:15,680 economics details, how much money they end their siblings to their past medical history. 152 00:11:15,680 --> 00:11:18,680 And then we also acts about their support exposures. 153 00:11:18,680 --> 00:11:24,680 We also, I'm telling you smoking and the exposures to as an all the best factors to as well. 154 00:11:24,680 --> 00:11:30,160 And again, the data also as a time of sort of a longer to know one year, the time we are 155 00:11:30,160 --> 00:11:35,240 seeing that patient with a certain patients, neurological examination and also do some score 156 00:11:35,240 --> 00:11:42,480 in their disability score and system like the EDSS patient disease disability scores. 157 00:11:42,480 --> 00:11:47,240 And we do all sorts of things as well as log in their laboratory, investigation as well 158 00:11:47,240 --> 00:11:49,240 as MRI images. 159 00:11:49,240 --> 00:11:54,680 If they do have the most of the most of them, well, the registry has quite a number of them. 160 00:11:54,680 --> 00:11:59,320 So we log in the lesions, bed in the head, which areas they do have. 161 00:11:59,320 --> 00:12:02,800 So that's what the registry sort of encompass. 162 00:12:02,800 --> 00:12:04,840 And finally, what's their diagnosis? 163 00:12:04,840 --> 00:12:08,800 And it is MS with subtype, sub-illapsing remits. 164 00:12:08,800 --> 00:12:11,760 And if it's NMO or the remog, we do. 165 00:12:11,760 --> 00:12:19,480 And by end of the 25, I think I had about 54 patients or so. 166 00:12:19,480 --> 00:12:24,520 My majority of them are crystal 70 of them was most, most of the risk to my surprise because 167 00:12:24,520 --> 00:12:30,320 I thought like we thought MS was rare and it was more common in our setting. 168 00:12:30,320 --> 00:12:34,920 But then this about 30 or so percent, about 30 percent of them was NM. 169 00:12:34,920 --> 00:12:37,760 And it wasn't let's have a different, it's common. 170 00:12:37,760 --> 00:12:40,600 I mean, not just common, but it's also common worldwide. 171 00:12:40,600 --> 00:12:44,600 So the data sort of speaks to how common MS was. 172 00:12:44,600 --> 00:12:49,200 We had a few more at the time, but now, like I said, we've expanded the registry again because 173 00:12:49,200 --> 00:12:50,200 a lot of people keep referring. 174 00:12:50,200 --> 00:12:55,560 So now we have about 120, 23 patients or so currently. 175 00:12:55,560 --> 00:12:57,320 And again, it's still not changed. 176 00:12:57,320 --> 00:13:00,520 It's still had the same status of the NMO and then the MW. 177 00:13:00,520 --> 00:13:06,920 But I found that interesting about the MS and of course, in keeping, most of them in terms 178 00:13:06,920 --> 00:13:14,520 of their demography were young and average it was about 30 in both MS and NMO. 179 00:13:14,520 --> 00:13:20,400 They had an average age of that 10, it was more females compared to males. 180 00:13:20,400 --> 00:13:25,480 The battery is to one for MS and about seven is to one for the NMO in terms of females to 181 00:13:25,480 --> 00:13:27,240 males at the time. 182 00:13:27,240 --> 00:13:31,800 Interestingly, and wasn't keeping that mean most of the common symptoms, they presented 183 00:13:31,800 --> 00:13:36,240 as optic neuritis as well as transverse malitis for both of them. 184 00:13:36,240 --> 00:13:43,040 But the third was common for MS was more of the sensory symptoms which we also had for 185 00:13:43,040 --> 00:13:45,120 the MS. 186 00:13:45,120 --> 00:13:49,240 When it comes to treatment, there are diagnostics. 187 00:13:49,240 --> 00:13:57,840 The average length for diagnosis of patients with the median age of MSc was about four years 188 00:13:57,840 --> 00:14:01,680 for MS patients compared to NMO that was about two years. 189 00:14:01,680 --> 00:14:06,800 And again, I thought because of the severity of NMO that transverse malitis is a bilateral 190 00:14:06,800 --> 00:14:09,720 object close to blindness. 191 00:14:09,720 --> 00:14:15,480 So this patient sort of coming pick her and they are made the diagnosis of the MELEASU. 192 00:14:15,480 --> 00:14:21,360 MS was four years in the average and then two years on the average for NMO from the first 193 00:14:21,360 --> 00:14:23,960 symptom onset to when diagnosis was made. 194 00:14:23,960 --> 00:14:28,280 They also took them on the average about five months from first symptom onset to get an 195 00:14:28,280 --> 00:14:33,440 imaging done for both MS and NMO. 196 00:14:33,440 --> 00:14:41,280 Interestingly, just about 35% of all my MS patients were actually on the disease modified 197 00:14:41,280 --> 00:14:42,280 therapy. 198 00:14:42,280 --> 00:14:47,960 And majority of them were on non-dysis or modified type of summons steroids or sterosporine 199 00:14:47,960 --> 00:14:50,440 agents like as a therapy and MMAF. 200 00:14:50,440 --> 00:14:58,880 And the same story was the same for that of NMO just about 10% of these again 29% of these 201 00:14:58,880 --> 00:15:03,800 NMO patients were on disease modified therapy which was betuczumab at the other time. 202 00:15:03,800 --> 00:15:07,680 And most of them were on long time steroids and other steroids, sparing agents. 203 00:15:07,680 --> 00:15:12,680 And if you compare that EDSS score, of course there are EDSS score for MS and the average is 204 00:15:12,680 --> 00:15:19,160 about two compared to that of the NMO which is about four because the severity of the illness. 205 00:15:19,160 --> 00:15:23,040 So these are the data but I think the kind of it seems to be changing and it will change 206 00:15:23,040 --> 00:15:30,200 especially with the new improvement or the new insurance scheme which the government 207 00:15:30,200 --> 00:15:31,200 wants to take on. 208 00:15:31,200 --> 00:15:35,000 I think maybe we will start early treatment to use the EDSS score. 209 00:15:35,000 --> 00:15:41,200 We put most of them hopefully about 100% unless the patients decide not to take it for 210 00:15:41,200 --> 00:15:48,440 but that reasons might be on disease modified therapy. 211 00:15:48,440 --> 00:15:55,920 What are the biggest barriers to obtaining an MS or like a demyelinating diagnosis in 212 00:15:55,920 --> 00:15:58,120 many African countries? 213 00:15:58,120 --> 00:15:59,240 Yes so maybe. 214 00:15:59,240 --> 00:16:08,040 I mean we also did a study which was by Maya and it was across the continent from Zambia, 215 00:16:08,040 --> 00:16:10,840 Kenya, Ghana, I think in St. Paraguay. 216 00:16:10,840 --> 00:16:15,360 I mean most of the African countries sort of close to about 22 or more countries. 217 00:16:15,360 --> 00:16:20,800 I've tried from my see that after we had the vetial course we set up an affairs of African 218 00:16:20,800 --> 00:16:25,640 terms that was in two entrants for all the founders being probably again and Dr. Diana 219 00:16:25,640 --> 00:16:30,680 Seyla and being one of the main founders of the Derazuki. 220 00:16:30,680 --> 00:16:36,040 So we sort of send these questionnaires to these neurologists or people who tend to see 221 00:16:36,040 --> 00:16:42,600 these patients to find out the challenges was the new diagnosis challenge in terms of 222 00:16:42,600 --> 00:16:46,800 the kind of state of diagnosis for new in NERJ card disorders in Africa. 223 00:16:46,800 --> 00:16:55,160 One of the major things was that was the cost of the park leka at the especially MRI most 224 00:16:55,160 --> 00:17:02,160 of them attested to the fact that it was quite expensive and also the total lack of availability 225 00:17:02,160 --> 00:17:08,480 of these MRIs as well as other serum antibody testing was the main issue for these things 226 00:17:08,480 --> 00:17:10,920 in actually making the diagnosis. 227 00:17:10,920 --> 00:17:18,600 Again one by MSI by and the serum will actually show that like I said earlier on most of the 228 00:17:18,600 --> 00:17:23,640 issues that they have from his paper which was the global barrier to diagnosis of multiple 229 00:17:23,640 --> 00:17:27,640 sclerosis which was more in low and in the country in South San Africa was that lack of 230 00:17:27,640 --> 00:17:33,680 patient awareness which is which was which is seen across the continent as well as half 231 00:17:33,680 --> 00:17:39,720 of the face now lack of awareness of symptoms again and most important availability of neurologists 232 00:17:39,720 --> 00:17:46,320 on the continent and like I said for me for example is just 18 patients 18 neurologists in 233 00:17:46,320 --> 00:17:52,560 a population about 35 million in Africa just about 0.1 per 100,000 neurologists so that 234 00:17:52,560 --> 00:17:58,000 was also a big challenge and of course the other thing was the diagnostic which we also 235 00:17:58,000 --> 00:18:00,400 found in our study. 236 00:18:00,400 --> 00:18:05,320 So these are some of the biggest challenges found and amazing thing with the paper we said 237 00:18:05,320 --> 00:18:11,720 were the people they arrested or diagnosed with a new medical disorder so that the availability 238 00:18:11,720 --> 00:18:20,080 of these images or parking that news were more found in the air band area in a few places 239 00:18:20,080 --> 00:18:26,200 so there was some disparity again so we believe there are a lot of MS patients and other 240 00:18:26,200 --> 00:18:30,200 dematurgymatic patients out there but look we get to not say so a neurologist who diagnosed 241 00:18:30,200 --> 00:18:34,240 it with a child because it's found in the air band rich places and also if you look 242 00:18:34,240 --> 00:18:38,760 at within the continent itself then upper middle income countries had more of these things 243 00:18:38,760 --> 00:18:40,560 compared to low bit of countries. 244 00:18:40,560 --> 00:18:44,280 Do there some countries that even they have just about one of these part connected to 245 00:18:44,280 --> 00:18:48,880 so it's a huge challenge in a part of the world when you really want to diagnose a patient 246 00:18:48,880 --> 00:18:50,480 of MS. 247 00:18:50,480 --> 00:18:57,640 It seems that something that's been really helpful for increasing like the number of patients 248 00:18:57,640 --> 00:19:04,200 in your registry and that referrals may you've been mentioning is how other specialists 249 00:19:04,200 --> 00:19:11,880 and other providers and doctors are kind of recognizing more of these signs and symptoms 250 00:19:11,880 --> 00:19:15,360 of a potential demyelinating disease. 251 00:19:15,360 --> 00:19:22,560 Can you tell me more about the education that you've provided to kind of help with these 252 00:19:22,560 --> 00:19:29,360 other like practitioners to kind of refer patients to you? 253 00:19:29,360 --> 00:19:37,360 So this is the course we did I think for primary by May 2024 and after that we set up the 254 00:19:37,360 --> 00:19:43,360 AFRIC trims and so we have a monthly web sessions and updates on what is going on MS. 255 00:19:43,360 --> 00:19:48,440 But then what we really did when we really did it in May 2024 when we did the VHR MS course 256 00:19:48,440 --> 00:19:55,640 in Africa was a 5B VHR course was delivered via Zoom and then like I said we included all 257 00:19:55,640 --> 00:20:02,240 the other such car flows like the pharmacologists and the news stations and sometimes orthopedics 258 00:20:02,240 --> 00:20:03,240 to as well. 259 00:20:03,240 --> 00:20:08,440 We read as a majority of the people who joined were general practitioners who's not had any 260 00:20:08,440 --> 00:20:12,800 other substatial training or they're in telemedicine and these are the people that seem to see 261 00:20:12,800 --> 00:20:13,800 them. 262 00:20:13,800 --> 00:20:20,920 We also realized that we also had a lot of people who joined the 10R medicine residents 263 00:20:20,920 --> 00:20:26,040 or physicians specialists at the time and then the rest were pharmacologists followed by 264 00:20:26,040 --> 00:20:27,400 the surgeons. 265 00:20:27,400 --> 00:20:35,240 And so before the study we did a pre-savvy course and an objective course survey for them 266 00:20:35,240 --> 00:20:41,080 or what they knew about MS and then we did a pre-savvy just to compare whether it's been 267 00:20:41,080 --> 00:20:45,560 improvement in that analysis and also did at the end of the survey at the end of the education 268 00:20:45,560 --> 00:20:49,360 fund, they're familiarity and whether they like the course. 269 00:20:49,360 --> 00:20:56,200 So I could say that we had about 800 participants joining about from 22 African countries and 270 00:20:56,200 --> 00:21:03,120 these were many anglophone because the education was delivered in English so we do a many anglophone 271 00:21:03,120 --> 00:21:10,080 countries that had it also had 5 for courted from five different countries in Africa. 272 00:21:10,080 --> 00:21:16,400 Like I said, which is cross-cryrace from North, West, East and then the south and parts of Africa 273 00:21:16,400 --> 00:21:18,320 as a faculty. 274 00:21:18,320 --> 00:21:26,440 So at the end of the, in the most of the topics we touched on was the symptoms of MS, the 275 00:21:26,440 --> 00:21:32,200 mimics of MS, the optically the rights of terminology aspects of MS, you know, and they 276 00:21:32,200 --> 00:21:36,160 also talk about the epidemiology of MS too as well. 277 00:21:36,160 --> 00:21:42,000 And then we also talk about the treatment and the moneyment of both acute and acute relapse 278 00:21:42,000 --> 00:21:45,400 and how to also prevent further relapses. 279 00:21:45,400 --> 00:21:49,920 So these were things we touched on and then at the end of the day, we realized that the 280 00:21:49,920 --> 00:21:58,840 familiarity of MS had improved about about that's 1% from before and after the course, 281 00:21:58,840 --> 00:22:03,600 their confidence now in diagnosis and MS had also improved about 32%. 282 00:22:03,600 --> 00:22:07,600 And the knowledge in managing MS had also improved about 40% which was also statistically 283 00:22:07,600 --> 00:22:08,600 significant. 284 00:22:08,600 --> 00:22:13,400 In fact, when we did a knowledge assessment score, the pre-emputed was a huge jump from our 285 00:22:13,400 --> 00:22:19,120 60% to 75% of them had a good score at the time. 286 00:22:19,120 --> 00:22:21,120 And so of course, we also started significantly. 287 00:22:21,120 --> 00:22:25,560 And then we did ask them whether they rated them as two as well if I'm to the African setting 288 00:22:25,560 --> 00:22:29,840 or the regional and 95% said it was relevant. 289 00:22:29,840 --> 00:22:35,720 97% of them said that we are 10 similar course and of course, as we see in our webnets, 290 00:22:35,720 --> 00:22:40,680 we do attend or the monthly webnets and also 97% of the recommended colleagues. 291 00:22:40,680 --> 00:22:44,600 So we realized that a lot of the just the momentum that created for this at the case, people 292 00:22:44,600 --> 00:22:49,360 that joined, so we created an African Zoom platform in our website. 293 00:22:49,360 --> 00:22:54,920 Most of our communities on the WhatsApp, sorry. 294 00:22:54,920 --> 00:22:56,400 And we have our monthly sessions. 295 00:22:56,400 --> 00:23:01,000 We talked about this has been done on the continent related to MS. 296 00:23:01,000 --> 00:23:05,280 We've been recently, we talked about the new market doing that criteria and how to use 297 00:23:05,280 --> 00:23:06,280 it. 298 00:23:06,280 --> 00:23:07,440 We also talked about other methods. 299 00:23:07,440 --> 00:23:13,080 And so every month it's a sort of web or web and accession, growing on and most of these 300 00:23:13,080 --> 00:23:15,720 participants actually do join. 301 00:23:15,720 --> 00:23:16,720 And so it's been very helpful. 302 00:23:16,720 --> 00:23:21,360 And like I said, I've seen it for my parts in Ghana because look every now and then you 303 00:23:21,360 --> 00:23:25,120 get people calling you and they also are aware that I run a clinic on Tuesdays and 304 00:23:25,120 --> 00:23:28,680 then they sort of find out what I think would be their preference for the next of the 305 00:23:28,680 --> 00:23:30,560 day or how agent it is. 306 00:23:30,560 --> 00:23:35,320 We also set up another infusion room to receive treatment and those are our cute flats. 307 00:23:35,320 --> 00:23:39,920 So yes, I must say the only downside is sometimes of a woman, but I enjoy what I do and 308 00:23:39,920 --> 00:23:45,520 other colleagues also help me very instrumental as being my boss, Professor Albeca Palou and 309 00:23:45,520 --> 00:23:50,240 Professor G who's been very helpful in actually sort of encouraging me to set up these 310 00:23:50,240 --> 00:23:54,920 registry, the clinics and they also been helpful in managing the cases for me too. 311 00:23:54,920 --> 00:23:55,920 Thank you. 312 00:23:55,920 --> 00:24:03,640 That's really great that you've built that community for other providers to learn more. 313 00:24:03,640 --> 00:24:11,360 With that kind of in mind in building a community, I wanted to switch gears and talk more about 314 00:24:11,360 --> 00:24:13,720 the AFRIC trims. 315 00:24:13,720 --> 00:24:19,080 Can you tell us more about what AFRIC trims is and how it came to be? 316 00:24:19,080 --> 00:24:22,560 Yeah, but that's, I'm always enjoying talking about AFRIC trims. 317 00:24:22,560 --> 00:24:25,680 The new kit on the block is the new trims. 318 00:24:25,680 --> 00:24:30,760 It's like it says, "I've done a committee for research and treatment in most of the cases." 319 00:24:30,760 --> 00:24:33,120 This was really established in 2024. 320 00:24:33,120 --> 00:24:37,200 My main founder is a game, Diana Sila and Dura Zoki. 321 00:24:37,200 --> 00:24:42,600 I think the idea came when we had a meeting in Kenya, which was organized by Dura Zoki and 322 00:24:42,600 --> 00:24:45,960 then Professor Sila bought up an idea of forming the AFRIC. 323 00:24:45,960 --> 00:24:48,200 It's gone through a lot of changes in the name. 324 00:24:48,200 --> 00:24:51,720 It used to be AFRIC trims and now there's many AFRIC trims. 325 00:24:51,720 --> 00:25:03,000 So in 2024, we actually had our first meeting and our conference in Ghana this year in May. 326 00:25:03,000 --> 00:25:06,480 We did it during the MSD in the State of the Pacific. 327 00:25:06,480 --> 00:25:10,960 And before that, we actually also had our patients D at the time. 328 00:25:10,960 --> 00:25:13,360 There's a lot of participants came. 329 00:25:13,360 --> 00:25:18,360 We had about 134 patients in Kegi race attended, which was very, very good. 330 00:25:18,360 --> 00:25:19,960 They really enjoyed themselves. 331 00:25:19,960 --> 00:25:22,680 We also had FACWASIs from not just the continent. 332 00:25:22,680 --> 00:25:28,080 We had FACWASIs from North America, at some, from Africa, from the US, and they were all 333 00:25:28,080 --> 00:25:29,080 there. 334 00:25:29,080 --> 00:25:34,960 It was a very good patch with the patient, which was where they could access the aspects. 335 00:25:34,960 --> 00:25:36,880 And so they access them a lot of questions. 336 00:25:36,880 --> 00:25:40,280 So we did have two scientific days soon after that. 337 00:25:40,280 --> 00:25:42,040 That's the test event at the first. 338 00:25:42,040 --> 00:25:47,120 And then we had again another educational sessions of talking about the MSD, the latest things, 339 00:25:47,120 --> 00:25:49,560 the MSD diagnosis, and all. 340 00:25:49,560 --> 00:25:56,440 We had an extensive session on the FACWASD, which is given by FACWASIs from across the continent. 341 00:25:56,440 --> 00:26:04,960 We even had our ACT-CHIMS presidents also presenting on a conference, which was great. 342 00:26:04,960 --> 00:26:07,440 And for him, he did was very, very good. 343 00:26:07,440 --> 00:26:08,440 This time included that. 344 00:26:08,440 --> 00:26:12,400 Franco-Fuens, so he was very helpful in giving the lectures for the FACWASI phone countries, 345 00:26:12,400 --> 00:26:14,560 which they also participated. 346 00:26:14,560 --> 00:26:19,240 We had a lot of people submitting the abstract, who was about 50 of them, about the research 347 00:26:19,240 --> 00:26:23,000 that they've done in Africa, and eventually moving forward. 348 00:26:23,000 --> 00:26:29,560 And I might say that the next meeting conference will be in Kenya next year, the day to be coming 349 00:26:29,560 --> 00:26:31,080 out very, very soon. 350 00:26:31,080 --> 00:26:34,520 And so there's a small community which we started growing, but it's become very huge. 351 00:26:34,520 --> 00:26:40,520 With a lot of other people being very genuinely interested and involved, not from the African 352 00:26:40,520 --> 00:26:47,160 continent, but other, continuing like the European countries as well as the US and North American 353 00:26:47,160 --> 00:26:48,160 being involved. 354 00:26:48,160 --> 00:26:55,440 So it's a young community that has a lot of potential, and we hope to change the story 355 00:26:55,440 --> 00:26:59,560 of MS and other demonets in the disease in the parts of the world to better improve 356 00:26:59,560 --> 00:27:05,400 the patient's care and also advance a lot of risks in our parts of the world. 357 00:27:05,400 --> 00:27:12,440 What was it like for you when you saw that first African conference come to life when you 358 00:27:12,440 --> 00:27:18,880 saw these people who were coming together to talk about the latest in treatment and 359 00:27:18,880 --> 00:27:20,880 research in MS? 360 00:27:20,880 --> 00:27:29,440 Yeah, so in each of you know, so again, when I brought Diana and her, you know, Sinan 361 00:27:29,440 --> 00:27:34,040 Derazoki, first, Emil Alhad, why don't you do our first meeting and why don't you do 362 00:27:34,040 --> 00:27:35,040 in Ghana? 363 00:27:35,040 --> 00:27:40,880 I mean, I thought I would never, I mean, I thought it was not possible, but and also I also 364 00:27:40,880 --> 00:27:47,320 thought maybe we just have a couple of maybe at most about 50 people or something at the 365 00:27:47,320 --> 00:27:48,320 conference. 366 00:27:48,320 --> 00:27:52,680 I was really amazed, you know, especially the patient, the, where most of my patients tend 367 00:27:52,680 --> 00:27:57,800 out, you know, and then the most touching thing and was, as was really touching, they were 368 00:27:57,800 --> 00:28:01,800 willing to share their experiences of what they've been to and encourage the other 369 00:28:01,800 --> 00:28:07,560 patients, they gave you about 110 before of them actually present with their caregivers 370 00:28:07,560 --> 00:28:12,520 too and sort of encourage and sort of strengthen the association they already had. 371 00:28:12,520 --> 00:28:16,280 And again, like I said, we were now able to secure insurance. 372 00:28:16,280 --> 00:28:18,920 So I was really, really impressed about it. 373 00:28:18,920 --> 00:28:23,780 And then also the main thing was the actual scientific conferences, you know, seeing the 374 00:28:23,780 --> 00:28:30,680 faculty see, you know, the members and we had about 180 people joining in person with 375 00:28:30,680 --> 00:28:34,760 over 400 of them being on, or they are veterans. 376 00:28:34,760 --> 00:28:38,120 I was, you know, it was a big, it was a huge surprise. 377 00:28:38,120 --> 00:28:44,440 I didn't, I didn't, I didn't expect that huge, the enthusiasm, the knowledge said, faculty 378 00:28:44,440 --> 00:28:45,440 for everybody everywhere. 379 00:28:45,440 --> 00:28:50,460 And again, you know, we had faculty again from Utah, we had for UN, we had for a lot of 380 00:28:50,460 --> 00:28:54,840 places coming in and again, as and now, even though we finished with Africa, they are 381 00:28:54,840 --> 00:29:01,440 all in the community, they reach out every now and then with how, what we are doing and 382 00:29:01,440 --> 00:29:03,840 when is the next one coming, they are willing to join. 383 00:29:03,840 --> 00:29:10,680 And I really saw big, big people in the MSPs, made a lot of names, joined our conference. 384 00:29:10,680 --> 00:29:18,120 To me, it was a huge, and it was a, it was a huge experience to sort of even talk to them 385 00:29:18,120 --> 00:29:23,160 and also sort of having interactions and network with these people. 386 00:29:23,160 --> 00:29:27,040 And they genuinely had the interest in to improve MSK and self-scihness. 387 00:29:27,040 --> 00:29:35,720 What has been the response from neurologists around the world regarding the conference and 388 00:29:35,720 --> 00:29:38,600 regarding this community that you're building? 389 00:29:38,600 --> 00:29:42,800 Now because of the meeting conference, Africa is being put on the map and everybody's 390 00:29:42,800 --> 00:29:46,480 really keep actually getting a lot of emails, a lot of WhatsApp for the next one. 391 00:29:46,480 --> 00:29:50,720 And even interesting, we even have our recordings recorded. 392 00:29:50,720 --> 00:29:55,520 And one of the most things we had a lot of new audiences across the world to add, the other 393 00:29:55,520 --> 00:29:58,000 recorded versions of these things and hopefully we did. 394 00:29:58,000 --> 00:30:07,200 So very soon, we hope to get uploaded online for everybody to sort of find out what actually 395 00:30:07,200 --> 00:30:08,200 went into the conference. 396 00:30:08,200 --> 00:30:12,040 But like I said, we've expanded after the conference. 397 00:30:12,040 --> 00:30:15,040 Most people, they're really interested and really want to join. 398 00:30:15,040 --> 00:30:18,400 And they keep asking when is the next one coming. 399 00:30:18,400 --> 00:30:22,280 So that's what I'm quite excited about. 400 00:30:22,280 --> 00:30:25,720 Yeah, it sounds like a really great conference. 401 00:30:25,720 --> 00:30:31,680 I know that my colleagues, Dr. Crain and Dr. Kiddish, who went there this past year, 402 00:30:31,680 --> 00:30:33,200 is going to be a bit. 403 00:30:33,200 --> 00:30:39,120 So I know that you're building a really great thing that so many people are really engaged 404 00:30:39,120 --> 00:30:45,520 in it and it definitely is making care for your patients better. 405 00:30:45,520 --> 00:30:54,280 Well, I think that was also inspiring to hear about everything that you've been doing. 406 00:30:54,280 --> 00:31:00,720 I just wanted to talk about the future a little bit and I wanted to know from you, what 407 00:31:00,720 --> 00:31:10,400 gives you optimism about the care for your patients about the global neurology community, 408 00:31:10,400 --> 00:31:13,480 what's giving you optimism and hope for the future? 409 00:31:13,480 --> 00:31:18,960 Yeah, so what's giving me hope for the future, all the optimism is it finds like a right 410 00:31:24,360 --> 00:31:25,800 come out and push in. 411 00:31:25,800 --> 00:31:27,600 You know, like I said, there's a big push. 412 00:31:27,600 --> 00:31:31,960 And I asked it when I was really one of our main sponsors in for this after Christmas 413 00:31:31,960 --> 00:31:38,360 at Tramps, as well as MSI, ASMR Foundation, you know, all these people navigate in 414 00:31:38,360 --> 00:31:44,520 and live on the level of my MS, all these people were sort of really, really interested in 415 00:31:44,520 --> 00:31:47,080 the hope and they keep access to what they could hope. 416 00:31:47,080 --> 00:31:52,040 Like I said, some of our funders in exchange is a huge sponsor of this program, which we are 417 00:31:52,040 --> 00:31:53,560 really thankful for. 418 00:31:53,560 --> 00:31:59,720 And then they actually not just give us fans, but actively participate in it. 419 00:31:59,720 --> 00:32:03,160 They keep sending us emails to find out how basic and how. 420 00:32:03,160 --> 00:32:07,000 And so I think moving forward with a lot of the future, seems to be very bright, with a lot 421 00:32:07,000 --> 00:32:10,120 of us coming together for the common goal in Africa. 422 00:32:10,120 --> 00:32:14,520 The other thing is also the neurologist and also the other clinicians on the African continent 423 00:32:14,520 --> 00:32:17,640 that tests for knowledge, that the tests to do something great. 424 00:32:17,640 --> 00:32:21,080 Like I said, most people are setting up registries. 425 00:32:21,080 --> 00:32:26,200 Now we, before we had just maybe in Kenya and Zambia, but a lot of people are setting up registries 426 00:32:26,200 --> 00:32:29,280 from Nigeria and we're having Ghana. 427 00:32:29,280 --> 00:32:33,640 So a lot of all these people are rich out to see how do you go about your registry? 428 00:32:33,640 --> 00:32:34,960 How can you go about how can you hope? 429 00:32:34,960 --> 00:32:39,240 And I think after tracing the better positions to sort of set up these registries, just 430 00:32:39,240 --> 00:32:44,720 even we hope to be able to get a continent, a sort of registry, which is a lot of clinical 431 00:32:44,720 --> 00:32:49,480 trials, which is a lot of research in the understanding of Amazon that part of the world. 432 00:32:49,480 --> 00:32:52,480 And who knows, I mean, there will be something coming out from Africa. 433 00:32:52,480 --> 00:32:54,920 So I'm really optimistic about it. 434 00:32:54,920 --> 00:33:00,960 We started, there's a big momentum there and there's a huge force and people are willing, 435 00:33:00,960 --> 00:33:06,800 just from the continent, but like you said, the global, the global and the biology communities 436 00:33:06,800 --> 00:33:10,080 really willing to make sure our supreme succeed. 437 00:33:10,080 --> 00:33:13,680 And I can see that happening, thank you. 438 00:33:13,680 --> 00:33:22,720 And my last question for you is, what advice do you have for trainees for young clinicians 439 00:33:22,720 --> 00:33:25,040 or even for policymakers? 440 00:33:25,040 --> 00:33:31,960 Yeah, so sometimes, well, especially for young trainees is sometimes things are not happening 441 00:33:31,960 --> 00:33:37,120 because we are not initiating things, and I want to talk about advocacy. 442 00:33:37,120 --> 00:33:40,000 You know, we have a lot we can do. 443 00:33:40,000 --> 00:33:43,600 And you see, sometimes the young, a person in a particular group, I think, well, the government 444 00:33:43,600 --> 00:33:44,600 is not interested. 445 00:33:44,600 --> 00:33:47,800 The government was very ignorant about it. 446 00:33:47,800 --> 00:33:49,480 I could see all the policies and make it. 447 00:33:49,480 --> 00:33:52,240 When I showed them the data, they were moving, they were touched. 448 00:33:52,240 --> 00:33:55,960 They didn't know, somebody actually said, they didn't know this was Ghana. 449 00:33:55,960 --> 00:33:58,320 And these were clinicians who were in big positions. 450 00:33:58,320 --> 00:34:00,960 And so I think advocacy is a big thing. 451 00:34:00,960 --> 00:34:05,960 You need to sort of start with a little, you have like a little registry, you can sort of 452 00:34:05,960 --> 00:34:07,560 let them know this is there. 453 00:34:07,560 --> 00:34:11,840 They didn't even know that the problem, and I actually made down the out of pocket payments, 454 00:34:11,840 --> 00:34:14,160 you know, and you could see the home was quiet. 455 00:34:14,160 --> 00:34:17,720 Look, this is too much for patients to go through. 456 00:34:17,720 --> 00:34:21,480 And so that's why they sort of, and again, the global, you have to give a big thanks 457 00:34:21,480 --> 00:34:25,360 to MSI, they made a big push to start off with the BWH, all the same. 458 00:34:25,360 --> 00:34:29,840 So I always want to talk to the young pennies and the young, well, I've come out of the 459 00:34:29,840 --> 00:34:30,840 don't give up. 460 00:34:30,840 --> 00:34:34,400 If you see, if you, you are only successful when you see a problem and you really want to 461 00:34:34,400 --> 00:34:36,440 meet that need, isn't it? 462 00:34:36,440 --> 00:34:37,440 And that's through advocacy. 463 00:34:37,440 --> 00:34:42,160 You will be surprised that look, people do not even know about these things. 464 00:34:42,160 --> 00:34:46,160 And people, there are a lot of good people out there who are willing to jump in your course 465 00:34:46,160 --> 00:34:47,160 and make it happen. 466 00:34:47,160 --> 00:34:49,160 So that, they shouldn't give up. 467 00:34:49,160 --> 00:34:52,280 It's still light at the end of the tunnel and it seems bright. 468 00:34:52,280 --> 00:34:58,160 And I encourage them to keep on wishing, especially with advocacy for their patients and for 469 00:34:58,160 --> 00:35:04,720 neurology care in our part of the world. 470 00:35:04,720 --> 00:35:06,880 Thank you for listening to No Brain Behind. 471 00:35:06,880 --> 00:35:11,480 No Brain Behind is the official podcast of the Society for Equity and Neuroscience. 472 00:35:11,480 --> 00:35:15,160 Opinions shared in this episode are those of the individuals being interviewed. 473 00:35:15,160 --> 00:35:19,240 To hear more from the sequence, subscribe to the podcast, follow us on social media and 474 00:35:19,240 --> 00:35:20,240 give us feedback. 475 00:35:20,240 --> 00:35:22,400 And what we would like to hear in future episodes. 476 00:35:22,400 --> 00:35:27,480 No Brain Behind is brought to you by the Society for Equity and Neuroscience, led by Dr. Bruce 477 00:35:27,480 --> 00:35:29,680 Obiagli and Liana Mascro. 478 00:35:29,680 --> 00:35:34,440 This podcast is produced by Dr. Vanessa Cooper, Rachel Foreman and Parnit Graywall. 479 00:35:34,440 --> 00:35:39,600 And our production team includes Sonia Glitcher, Tino Delamer said, Joshua Homs, Euchain 480 00:35:39,600 --> 00:35:45,120 Hoang, Dr. Angel Cadena Tejada, Gatangeli Doss and Chris Orlando are hosts. 481 00:35:45,120 --> 00:35:55,120 [MUSIC]